Success Metrics

Clinical Success Rate
100.0%

Based on 13 completed trials

Completion Rate
100%(13/13)
Active Trials
11(42%)
Results Posted
62%(8 trials)

Phase Distribution

Ph phase_1
4
15%
Ph not_applicable
13
50%
Ph phase_3
1
4%
Ph early_phase_1
5
19%

Phase Distribution

9

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution23 total trials
Early Phase 1First-in-human
5(21.7%)
Phase 1Safety & dosage
4(17.4%)
Phase 3Large-scale testing
1(4.3%)
N/ANon-phased studies
13(56.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

92.9%

13 of 14 finished

Non-Completion Rate

7.1%

1 ended early

Currently Active

11

trials recruiting

Total Trials

26

all time

Status Distribution
Active(11)
Completed(13)
Terminated(1)
Other(1)

Detailed Status

Completed13
Recruiting10
Active, not recruiting1
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
26
Active
11
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 15 (21.7%)
Phase 14 (17.4%)
Phase 31 (4.3%)
N/A13 (56.5%)

Trials by Status

active_not_recruiting14%
unknown14%
withdrawn14%
recruiting1038%
completed1350%

Recent Activity

11 active trials
Showing 5 of 26
recruitingnot_applicable

TMS-based Assessment of Mental Training Effects on Motor Learning in Healthy Participants

NCT04784832
recruitingearly_phase_1

Ketamine and Propofol NeuroImaging

NCT07294092
completedearly_phase_1

Sevoflurane's Effect on Neurocognition Study

NCT06044740
recruitingearly_phase_1

Nitrous Oxide Neuroimaging

NCT06702631
recruitingearly_phase_1

Early Feasibility of the Nervonik Peripheral Nerve Stimulation Device

NCT06772142
View all 26 trials

Clinical Trials (26)

Showing 20 of 26 trialsScroll for more
NCT04784832Not Applicable

TMS-based Assessment of Mental Training Effects on Motor Learning in Healthy Participants

Recruiting
NCT07294092Early Phase 1

Ketamine and Propofol NeuroImaging

Recruiting
NCT06044740Early Phase 1

Sevoflurane's Effect on Neurocognition Study

Completed
NCT06702631Early Phase 1

Nitrous Oxide Neuroimaging

Recruiting
NCT06772142Early Phase 1

Early Feasibility of the Nervonik Peripheral Nerve Stimulation Device

Recruiting
NCT07290205Early Phase 1

Remimazolam NeuroImaging

Recruiting
NCT01019343Not Applicable

Physiological Investigations of Movement Disorders

Completed
NCT06162403Not Applicable

Exploring the Benefit of Peripheral Nerve Stimulation in Treating Pain From Chemo-induced Peripheral Neuropathy: A Longitudinal Single Center Feasibility Study

Recruiting
NCT04713098Not Applicable

Ultrasound-Guided Percutaneous Peripheral Nerve Stimulation: A Department of Defense Funded Pragmatic Clinical Trial

Completed
NCT02893267Not Applicable

Multimodal Treatment for Hemiplegic Shoulder Pain

Completed
NCT04947865Not Applicable

Reflex Excitability in Post-stroke Stiff-Knee Gait

Active Not Recruiting
NCT06741579Phase 3

Mechanisms of Stimulation for Pain Alleviation

Recruiting
NCT06293638

Functional Brain Network Changes in Patients Undergoing Deep Brain Stimulation for Essential Tremor

Recruiting
NCT04062123Phase 1

Memory & Conditioning Under Anesthesia

Completed
NCT06113965Not Applicable

Neural Operant Conditioning

Withdrawn
NCT05501600Phase 1

Neural Correlates of Lidocaine Analgesia

Completed
NCT06702904Not Applicable

Evaluation of Neuroprosthesis with Sensory Feedback for Modulation of Phantom Limb Pain and Enhancing Quality of Life

Recruiting
NCT06644807Not Applicable

Study of Phantom Limb Pain Suppression Using Neuromodulation Methods

Recruiting
NCT04066374Not Applicable

Feasibility Study for Intrathoracic Nerve Stimulation

Completed
NCT02587234Phase 1

Driving Neuroplasticity With Nerve Stimulation and Modified CIT

Completed

Drug Details

Intervention Type
DEVICE
Total Trials
26